Transatlantique Private Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,628
Closed -$742K 207
2025
Q3
$742K Sell
2,628
-51
-2% -$14.8K 0.24% 114
2025
Q2
$748K Sell
2,679
-535
-17% -$152K 0.28% 107
2025
Q1
$1M Sell
3,214
-167
-5% -$49.3K 0.4% 74
2024
Q4
$881K Sell
3,381
-88
-3% -$26.1K 0.33% 87
2024
Q3
$1.12M Hold
3,469
0.43% 70
2024
Q2
$1.08M Buy
3,469
+460
+15% +$135K 0.44% 62
2024
Q1
$856K Buy
3,009
+132
+5% +$38.6K 0.37% 94
2023
Q4
$829K Hold
2,877
0.39% 88
2023
Q3
$773K Buy
2,877
+4
+0.1% +$998 0.41% 85
2023
Q2
$638K Buy
2,873
+153
+6% +$35.5K 0.33% 96
2023
Q1
$658K Buy
2,720
+109
+4% +$26.8K 0.36% 92
2022
Q4
$686K Buy
2,611
+120
+5% +$32.2K 0.41% 79
2022
Q3
$561K Sell
2,491
-89
-3% -$21.6K 0.38% 89
2022
Q2
$628K Buy
+2,580
New +$632K 0.44% 83

Other funds holding AMGN

Transatlantique Private Wealth's AMGN Position: Q4 2025 in Review

Transatlantique Private Wealth sold out of Amgen (AMGN) in Q4 2025, closing a stake of 2,628 shares — an estimated $742K sold.

Transatlantique Private Wealth first reported a position in AMGN in Q2 2022 and held it in 14 quarters. The position peaked at $1.12M in Q3 2024. 3,086 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Transatlantique Private Wealth reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Transatlantique Private Wealth sold 2,628 Amgen shares in Q4 2025, an estimated $742K.
  • Transatlantique Private Wealth first reported a position in Amgen in Q2 2022 and held it in 14 quarters.
  • Transatlantique Private Wealth's Amgen position peaked at $1.12M in Q3 2024.
  • 3,086 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Transatlantique Private Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.